Cervical dystonia and substance abuse
Authors:
- For The Members Of The Dystonia CoalitionFCFor The Members Of The Dystonia Coalition
- Abhimanyu MahajanAMAbhimanyu Mahajan
- Neepa PatelNPNeepa Patel
- 22 March 2018
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 265 (4) , 970-975
Abstract
Objective To investigate the prevalence of substance abuse (SA) in patients with cervical dystonia (CD) and to correlate it with prevalence of psychiatric disorders. Methods Data on anxiety, depression, dystonia severity, and substance abuse were collected from ten sites participating in the Dystonia Coalition. Patients were divided into two groups according to the presence of SA, utilizing Structured Clinical Interview for DSM-4 criteria. Wilcoxon Rank-Sum test was used to analyze the difference in median scores on the questionnaires between the groups. Chi-square test was used to analyze association between opiate and benzodiazepine use and SA. Association between TWSTRS severity and SA and medication use was assessed. A two-tailed p value of < 0.05 was considered significant. SAS 9.3 (SAS Institute Inc., Cary, NC, USA) was used for all analyses. Results Of 208 CD patients, 23 (11%) were identified with SA; 26.3% of patients with SA were on opiates compared to 7.2% of CD patients without SA (p = 0.006). Compared to non-SA patients, those experiencing SA were more likely male (88.9%; p = 0.0007), younger (median age 55; p = 0.031), and scored worse on questionnaires assessing depression (p = 0.044, p = 0.005), anxiety (p = 0.003), and dystonia psychiatric severity (p = 0.033). The median TWSTRS motor severity scores were higher in SA patients compared to non-SA patients (20 versus 16, p = 0.0339). The median TWSTRS total disability, motor, and pain scores were higher in patients on opiates than patients who were not (12 versus 8, p = 0.0071; 18.5 versus 16, p = 0.0243; 12.4 versus 6.7, p = 0.0052, respectively). Conclusions Potential risk factors for SA in CD patients include younger age and male gender with comorbid anxiety, depression and other psychiatric problems. Caution should be exercised when prescribing drugs with potential for abuse in these patients.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (U54 NS065701)
- National Center for Advancing Translational Sciences (U54 TR001456)
This publication has 25 references indexed in Scilit:
- Dystonia treatmentNeurology, 2017
- Cervical dystonia and quality of lifeActa Neurologica Belgica, 2016
- Clinical course of psychiatric disorders in patients with cervical dystoniaPsychiatry Research, 2015
- An international survey of patients with cervical dystoniaJournal of Neurology, 2015
- Treatment of DystoniaNeurotherapeutics, 2014
- Psychiatric comorbidities in dystonia: Emerging conceptsMovement Disorders, 2013
- Phenomenology and classification of dystonia: A consensus updateMovement Disorders, 2013
- Prescription Use Disorders in Older AdultsThe American Journal on Addictions, 2010
- Psychiatric disorders in adult‐onset focal dystonia: A case‐control studyMovement Disorders, 2010
- Social phobia in spasmodic torticollisJournal of Neurology, Neurosurgery & Psychiatry, 2001